Clinical Roundup Enzalutamide drug combination cuts risk of death in advanced prostate cancer, Cedars-Sinai-led study shows October 24, 2025Vol.51 No.39
Clinical Roundup Alliance trial aims to improve outcomes in metastatic prostate cancer October 10, 2025Vol.51 No.37
Clinical Roundup Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows September 05, 2025Vol.51 No.32
In Brief UIC, Northwestern, Moffitt researchers awarded $1.2M DOD grant for prostate cancer research August 01, 2025Vol.51 No.30
Clinical Roundup Xtandi + ADT slow disease-progression in mHSPC compared to darolutamide + ADT July 18, 2025Vol.51 No.28
Clinical Roundup Xtandi + leuprolide improves OS in non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence, phase III data show July 11, 2025Vol.51 No.27
Clinical Roundup Biomarkers reveal clue in treating aggressive prostate cancer, phase II study finds June 06, 2025Vol.51 No.22
Drugs & Targets FDA approves Nubeqa for metastatic castration-sensitive prostate cancer June 06, 2025Vol.51 No.22
